Cell-Membrane-Coated and Cell-Penetrating Peptide-Conjugated Trimagnetic Nanoparticles for Targeted Magnetic Hyperthermia of Prostate Cancer Cells

ACS Appl Mater Interfaces. 2023 Jun 28;15(25):30008-30028. doi: 10.1021/acsami.3c07248. Epub 2023 Jun 13.

Abstract

Prostate malignancy represents the second leading cause of cancer-specific death among the male population worldwide. Herein, enhanced intracellular magnetic fluid hyperthermia is applied in vitro to treat prostate cancer (PCa) cells with minimum invasiveness and toxicity and highly specific targeting. We designed and optimized novel shape-anisotropic magnetic core-shell-shell nanoparticles (i.e., trimagnetic nanoparticles - TMNPs) with significant magnetothermal conversion following an exchange coupling effect to an external alternating magnetic field (AMF). The functional properties of the best candidate in terms of heating efficiency (i.e., Fe3O4@Mn0.5Zn0.5Fe2O4@CoFe2O4) were exploited following surface decoration with PCa cell membranes (CM) and/or LN1 cell-penetrating peptide (CPP). We demonstrated that the combination of biomimetic dual CM-CPP targeting and AMF responsiveness significantly induces caspase 9-mediated apoptosis of PCa cells. Furthermore, a downregulation of the cell cycle progression markers and a decrease of the migration rate in surviving cells were observed in response to the TMNP-assisted magnetic hyperthermia, suggesting a reduction in cancer cell aggressiveness.

Keywords: cell membranes; cell-penetrating peptides; intracellular hyperthermia; prostate cancer; trimagnetic nanoparticles.

MeSH terms

  • Cell Membrane
  • Cell-Penetrating Peptides*
  • Humans
  • Hyperthermia, Induced*
  • Magnetic Fields
  • Magnetite Nanoparticles* / chemistry
  • Magnetite Nanoparticles* / therapeutic use
  • Male
  • Nanoparticles* / chemistry
  • Prostatic Neoplasms* / therapy

Substances

  • Cell-Penetrating Peptides
  • Magnetite Nanoparticles